Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-26 @ 4:08 AM
Study NCT ID:
NCT04510818
Status:
UNKNOWN
Last Update Posted:
2020-08-14
First Post:
2020-08-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2)
Sponsor:
Ruijin Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-10
First Submit QC Date:
None
Study First Post Date:
2020-08-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-12
Last Update Post Date:
2020-08-14
Last Update Post Date Type:
ACTUAL